Sign Up for a Free Account

06.09.2025

Supporting cognitive flexibility in autistic individuals

Notice: News releases are not subject to review by MedLink Neurology’s Editorial Board.

Some autistic traits related to challenges with social interaction, mental flexibility, and visual perception could be alleviated through a new, noninvasive therapy. A team of researchers, including those from the University of Tokyo, found that stimulating nerve cells when the brain becomes “stuck” in a certain state improves flexibility and relieves some autistic behaviors. The procedure utilized transcranial magnetic stimulation, which is already used to treat certain mood disorders, in a novel manner. Over 40 adults with a mild form of autism participated, and the therapeutic effects lasted for up to two months after the last session. This study could contribute to projects enabling new treatments.

The number of people diagnosed with autism spectrum disorder has been increasing for several decades, partly due to improved testing and also understanding of this broad developmental condition. Autism spectrum disorder can affect how a person interacts socially and with their environment to varying degrees. This can manifest particularly tough challenges with communication and social interaction, as well as restrictive and repetitive behaviors.

Professor Takamitsu Watanabe, a psychiatrist and cognitive neuroscientist from the University of Tokyo’s International Research Center for Neurointelligence (WPI-IRCN), became interested in autism spectrum disorder after listening to his patients. “I realized various autistic traits were not fully accounted for in a biologically comprehensive manner, and thus, at least when I started my career as a psychiatrist some years ago, no neurobiological treatment was established. So, I began a series of studies,” he said.

Through their research, Watanabe and co-authors found that autistic adults and children experience what they refer to as neural rigidity. While our brains typically transit frequently between different states, even when we are simply resting, for some individuals with autism spectrum disorder, these changes occur less often, and the transition between states is relatively rare.

In the current study, Watanabe and co-researcher Hidenori Yamasue, from the Hamamatsu University School of Medicine in Japan, found that this neural rigidity is responsible for both social and nonsocial behaviors seen in autism spectrum disorder. They also identified the mechanisms by which neural rigidity affects such a variety of autistic cognitive traits.

“Our results clarify that neural rigidity doesn’t just correlate with autistic behaviors, but indicates the possibility that neural rigidity could be a major cause of this prevalent neurodevelopmental condition at the biological level,” said Watanabe. “These findings provide an account for how social, nonsocial, and perceptual characteristics seen in autism spectrum disorder can coexist in one individual, and how these diverse behavioral traits could emerge from one cause.”

Forty volunteer adults with level 1 autism spectrum disorder (the lowest severity on the three-level autism spectrum disorder scale) took part in the study, participating in multiple experiments over a 24-week period. The tests involved collecting brain-related data to understand the participants’ baseline brain dynamics, assessing their brains’ neural rigidity related to social and nonsocial autistic traits, and numerical simulations followed by physical trials of a method to increase neural flexibility.

The method applied by the researchers is called brain state-driven neural stimulation (BDNS). This noninvasive and painless procedure involves transcranial magnetic stimulation, which places magnets on the outside of the head to stimulate brain cells. This transcranial magnetic stimulation method itself has been used to improve symptoms of major depression in clinical situations. In their previous study, the researchers built a BDNS system by combining transcranial magnetic stimulation with brain-recording systems, such as functional MRI and electroencephalography. By integrating this brain-monitoring system with the neural stimulation method, they successfully delivered a short pulse of transcranial magnetic stimulation only when the brains of the participants became stuck in a specific state.

The team found that BDNS was able to influence participants’ brain-state dynamics, but were surprised by how it took effect. “We observed significant time lags between the effects of BDNS on different behaviors. Autistic cognitive inflexibility began to show a quick change even at week one, whereas perceptual and social traits took far longer,” explained Watanabe. “In particular, we and the participants had to wait for six to seven weeks for autistic social traits to start exhibiting significant changes.”

If BDNS is to be offered to adults with autism in the future, the team says that a larger and more diverse group, both in terms of age and levels of autism spectrum disorder, should be involved in further tests. An optimum protocol for applying the BDNS method also needs to be established for a longer-lasting effect. In this study, BDNS was applied weekly for 12 weeks, and the behavioral effects eventually disappeared about two months after the final session.

The possibilities of BDNS could, however, go beyond supporting people with autism spectrum disorder. “We are considering if this approach could be applied to other neuropsychiatric conditions, such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder,” said Watanabe. “In our previous study, we found a link between hyperactivity seen in ADHD and overflexibility of brain dynamics. We may be able to control overly flexible brain dynamics in conceptually the same way, which could relieve some ADHD behaviors. For now though, we hope our current work could form the basis for a new, noninvasive therapy option for a wide range of autistic traits.”

Source: News Release
University of Tokyo
June 8,
2025

Questions or Comment?

MedLink, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125